Global Biologics CDMO Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Biologics CDMO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Biologics CDMO players cover Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics and Toyobo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Biologics CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Biologics CDMO market, with both quantitative and qualitative data, to help readers understand how the Biologics CDMO market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Biologics CDMO market and forecasts the market size by Type (Biological Agent and Biosimilar Drug,), by Application (Cell Therapy, Drug Development and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Biologics CDMO, Research Methodology, etc.
Chapter 2: Executive Summary, global Biologics CDMO market size (sales and revenue) and CAGR, Biologics CDMO market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Biologics CDMO sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Biologics CDMO sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Biologics CDMO market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc and Boehringer Ingelheim, etc.
Chapter 14: Research Findings and Conclusion
The global market for Biologics CDMO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Biologics CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Biologics CDMO players cover Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics and Toyobo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Biologics CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Biologics CDMO market, with both quantitative and qualitative data, to help readers understand how the Biologics CDMO market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Biologics CDMO market and forecasts the market size by Type (Biological Agent and Biosimilar Drug,), by Application (Cell Therapy, Drug Development and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Biological Agent
- Biosimilar Drug
- Cell Therapy
- Drug Development
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza Group AG
- Samsung Biologics
- AbbVie
- WuXi Biologics
- Toyobo
- AGC
- Thermo Fisher Scientific
- ICON Plc
- Boehringer Ingelheim
- Fujifilm Diosynth Biotechnologies
Chapter 1: Scope of Biologics CDMO, Research Methodology, etc.
Chapter 2: Executive Summary, global Biologics CDMO market size (sales and revenue) and CAGR, Biologics CDMO market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Biologics CDMO sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Biologics CDMO sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Biologics CDMO market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc and Boehringer Ingelheim, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CDMO Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biologics CDMO by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biologics CDMO by Country/Region, 2017, 2022 & 2028
2.2 Biologics CDMO Segment by Type
2.2.1 Biological Agent
2.2.2 Biosimilar Drug
2.3 Biologics CDMO Sales by Type
2.3.1 Global Biologics CDMO Sales Market Share by Type (2017-2022)
2.3.2 Global Biologics CDMO Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biologics CDMO Sale Price by Type (2017-2022)
2.4 Biologics CDMO Segment by Application
2.4.1 Cell Therapy
2.4.2 Drug Development
2.4.3 Others
2.5 Biologics CDMO Sales by Application
2.5.1 Global Biologics CDMO Sale Market Share by Application (2017-2022)
2.5.2 Global Biologics CDMO Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biologics CDMO Sale Price by Application (2017-2022)
3 GLOBAL BIOLOGICS CDMO BY COMPANY
3.1 Global Biologics CDMO Breakdown Data by Company
3.1.1 Global Biologics CDMO Annual Sales by Company (2020-2022)
3.1.2 Global Biologics CDMO Sales Market Share by Company (2020-2022)
3.2 Global Biologics CDMO Annual Revenue by Company (2020-2022)
3.2.1 Global Biologics CDMO Revenue by Company (2020-2022)
3.2.2 Global Biologics CDMO Revenue Market Share by Company (2020-2022)
3.3 Global Biologics CDMO Sale Price by Company
3.4 Key Manufacturers Biologics CDMO Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics CDMO Product Location Distribution
3.4.2 Players Biologics CDMO Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICS CDMO BY GEOGRAPHIC REGION
4.1 World Historic Biologics CDMO Market Size by Geographic Region (2017-2022)
4.1.1 Global Biologics CDMO Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biologics CDMO Annual Revenue by Geographic Region
4.2 World Historic Biologics CDMO Market Size by Country/Region (2017-2022)
4.2.1 Global Biologics CDMO Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biologics CDMO Annual Revenue by Country/Region
4.3 Americas Biologics CDMO Sales Growth
4.4 APAC Biologics CDMO Sales Growth
4.5 Europe Biologics CDMO Sales Growth
4.6 Middle East & Africa Biologics CDMO Sales Growth
5 AMERICAS
5.1 Americas Biologics CDMO Sales by Country
5.1.1 Americas Biologics CDMO Sales by Country (2017-2022)
5.1.2 Americas Biologics CDMO Revenue by Country (2017-2022)
5.2 Americas Biologics CDMO Sales by Type
5.3 Americas Biologics CDMO Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CDMO Sales by Region
6.1.1 APAC Biologics CDMO Sales by Region (2017-2022)
6.1.2 APAC Biologics CDMO Revenue by Region (2017-2022)
6.2 APAC Biologics CDMO Sales by Type
6.3 APAC Biologics CDMO Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics CDMO by Country
7.1.1 Europe Biologics CDMO Sales by Country (2017-2022)
7.1.2 Europe Biologics CDMO Revenue by Country (2017-2022)
7.2 Europe Biologics CDMO Sales by Type
7.3 Europe Biologics CDMO Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CDMO by Country
8.1.1 Middle East & Africa Biologics CDMO Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biologics CDMO Revenue by Country (2017-2022)
8.2 Middle East & Africa Biologics CDMO Sales by Type
8.3 Middle East & Africa Biologics CDMO Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics CDMO
10.3 Manufacturing Process Analysis of Biologics CDMO
10.4 Industry Chain Structure of Biologics CDMO
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics CDMO Distributors
11.3 Biologics CDMO Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS CDMO BY GEOGRAPHIC REGION
12.1 Global Biologics CDMO Market Size Forecast by Region
12.1.1 Global Biologics CDMO Forecast by Region (2023-2028)
12.1.2 Global Biologics CDMO Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologics CDMO Forecast by Type
12.7 Global Biologics CDMO Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lonza Group AG
13.1.1 Lonza Group AG Company Information
13.1.2 Lonza Group AG Biologics CDMO Product Offered
13.1.3 Lonza Group AG Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lonza Group AG Main Business Overview
13.1.5 Lonza Group AG Latest Developments
13.2 Samsung Biologics
13.2.1 Samsung Biologics Company Information
13.2.2 Samsung Biologics Biologics CDMO Product Offered
13.2.3 Samsung Biologics Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Samsung Biologics Main Business Overview
13.2.5 Samsung Biologics Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie Biologics CDMO Product Offered
13.3.3 AbbVie Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 WuXi Biologics
13.4.1 WuXi Biologics Company Information
13.4.2 WuXi Biologics Biologics CDMO Product Offered
13.4.3 WuXi Biologics Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 WuXi Biologics Main Business Overview
13.4.5 WuXi Biologics Latest Developments
13.5 Toyobo
13.5.1 Toyobo Company Information
13.5.2 Toyobo Biologics CDMO Product Offered
13.5.3 Toyobo Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Toyobo Main Business Overview
13.5.5 Toyobo Latest Developments
13.6 AGC
13.6.1 AGC Company Information
13.6.2 AGC Biologics CDMO Product Offered
13.6.3 AGC Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AGC Main Business Overview
13.6.5 AGC Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Biologics CDMO Product Offered
13.7.3 Thermo Fisher Scientific Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 ICON Plc
13.8.1 ICON Plc Company Information
13.8.2 ICON Plc Biologics CDMO Product Offered
13.8.3 ICON Plc Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ICON Plc Main Business Overview
13.8.5 ICON Plc Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Biologics CDMO Product Offered
13.9.3 Boehringer Ingelheim Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Fujifilm Diosynth Biotechnologies
13.10.1 Fujifilm Diosynth Biotechnologies Company Information
13.10.2 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Offered
13.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Fujifilm Diosynth Biotechnologies Main Business Overview
13.10.5 Fujifilm Diosynth Biotechnologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CDMO Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biologics CDMO by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biologics CDMO by Country/Region, 2017, 2022 & 2028
2.2 Biologics CDMO Segment by Type
2.2.1 Biological Agent
2.2.2 Biosimilar Drug
2.3 Biologics CDMO Sales by Type
2.3.1 Global Biologics CDMO Sales Market Share by Type (2017-2022)
2.3.2 Global Biologics CDMO Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biologics CDMO Sale Price by Type (2017-2022)
2.4 Biologics CDMO Segment by Application
2.4.1 Cell Therapy
2.4.2 Drug Development
2.4.3 Others
2.5 Biologics CDMO Sales by Application
2.5.1 Global Biologics CDMO Sale Market Share by Application (2017-2022)
2.5.2 Global Biologics CDMO Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biologics CDMO Sale Price by Application (2017-2022)
3 GLOBAL BIOLOGICS CDMO BY COMPANY
3.1 Global Biologics CDMO Breakdown Data by Company
3.1.1 Global Biologics CDMO Annual Sales by Company (2020-2022)
3.1.2 Global Biologics CDMO Sales Market Share by Company (2020-2022)
3.2 Global Biologics CDMO Annual Revenue by Company (2020-2022)
3.2.1 Global Biologics CDMO Revenue by Company (2020-2022)
3.2.2 Global Biologics CDMO Revenue Market Share by Company (2020-2022)
3.3 Global Biologics CDMO Sale Price by Company
3.4 Key Manufacturers Biologics CDMO Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics CDMO Product Location Distribution
3.4.2 Players Biologics CDMO Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICS CDMO BY GEOGRAPHIC REGION
4.1 World Historic Biologics CDMO Market Size by Geographic Region (2017-2022)
4.1.1 Global Biologics CDMO Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biologics CDMO Annual Revenue by Geographic Region
4.2 World Historic Biologics CDMO Market Size by Country/Region (2017-2022)
4.2.1 Global Biologics CDMO Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biologics CDMO Annual Revenue by Country/Region
4.3 Americas Biologics CDMO Sales Growth
4.4 APAC Biologics CDMO Sales Growth
4.5 Europe Biologics CDMO Sales Growth
4.6 Middle East & Africa Biologics CDMO Sales Growth
5 AMERICAS
5.1 Americas Biologics CDMO Sales by Country
5.1.1 Americas Biologics CDMO Sales by Country (2017-2022)
5.1.2 Americas Biologics CDMO Revenue by Country (2017-2022)
5.2 Americas Biologics CDMO Sales by Type
5.3 Americas Biologics CDMO Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CDMO Sales by Region
6.1.1 APAC Biologics CDMO Sales by Region (2017-2022)
6.1.2 APAC Biologics CDMO Revenue by Region (2017-2022)
6.2 APAC Biologics CDMO Sales by Type
6.3 APAC Biologics CDMO Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics CDMO by Country
7.1.1 Europe Biologics CDMO Sales by Country (2017-2022)
7.1.2 Europe Biologics CDMO Revenue by Country (2017-2022)
7.2 Europe Biologics CDMO Sales by Type
7.3 Europe Biologics CDMO Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CDMO by Country
8.1.1 Middle East & Africa Biologics CDMO Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biologics CDMO Revenue by Country (2017-2022)
8.2 Middle East & Africa Biologics CDMO Sales by Type
8.3 Middle East & Africa Biologics CDMO Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics CDMO
10.3 Manufacturing Process Analysis of Biologics CDMO
10.4 Industry Chain Structure of Biologics CDMO
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics CDMO Distributors
11.3 Biologics CDMO Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS CDMO BY GEOGRAPHIC REGION
12.1 Global Biologics CDMO Market Size Forecast by Region
12.1.1 Global Biologics CDMO Forecast by Region (2023-2028)
12.1.2 Global Biologics CDMO Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologics CDMO Forecast by Type
12.7 Global Biologics CDMO Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lonza Group AG
13.1.1 Lonza Group AG Company Information
13.1.2 Lonza Group AG Biologics CDMO Product Offered
13.1.3 Lonza Group AG Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lonza Group AG Main Business Overview
13.1.5 Lonza Group AG Latest Developments
13.2 Samsung Biologics
13.2.1 Samsung Biologics Company Information
13.2.2 Samsung Biologics Biologics CDMO Product Offered
13.2.3 Samsung Biologics Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Samsung Biologics Main Business Overview
13.2.5 Samsung Biologics Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie Biologics CDMO Product Offered
13.3.3 AbbVie Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 WuXi Biologics
13.4.1 WuXi Biologics Company Information
13.4.2 WuXi Biologics Biologics CDMO Product Offered
13.4.3 WuXi Biologics Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 WuXi Biologics Main Business Overview
13.4.5 WuXi Biologics Latest Developments
13.5 Toyobo
13.5.1 Toyobo Company Information
13.5.2 Toyobo Biologics CDMO Product Offered
13.5.3 Toyobo Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Toyobo Main Business Overview
13.5.5 Toyobo Latest Developments
13.6 AGC
13.6.1 AGC Company Information
13.6.2 AGC Biologics CDMO Product Offered
13.6.3 AGC Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AGC Main Business Overview
13.6.5 AGC Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Biologics CDMO Product Offered
13.7.3 Thermo Fisher Scientific Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 ICON Plc
13.8.1 ICON Plc Company Information
13.8.2 ICON Plc Biologics CDMO Product Offered
13.8.3 ICON Plc Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ICON Plc Main Business Overview
13.8.5 ICON Plc Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Biologics CDMO Product Offered
13.9.3 Boehringer Ingelheim Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Fujifilm Diosynth Biotechnologies
13.10.1 Fujifilm Diosynth Biotechnologies Company Information
13.10.2 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Offered
13.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Fujifilm Diosynth Biotechnologies Main Business Overview
13.10.5 Fujifilm Diosynth Biotechnologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics CDMO Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biologics CDMO Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Biological Agent
Table 4. Major Players of Biosimilar Drug
Table 5. Global Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 6. Global Biologics CDMO Sales Market Share by Type (2017-2022)
Table 7. Global Biologics CDMO Revenue by Type (2017-2022) & ($ million)
Table 8. Global Biologics CDMO Revenue Market Share by Type (2017-2022)
Table 9. Global Biologics CDMO Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 11. Global Biologics CDMO Sales Market Share by Application (2017-2022)
Table 12. Global Biologics CDMO Revenue by Application (2017-2022)
Table 13. Global Biologics CDMO Revenue Market Share by Application (2017-2022)
Table 14. Global Biologics CDMO Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Biologics CDMO Sales by Company (2020-2022) & (K Units)
Table 16. Global Biologics CDMO Sales Market Share by Company (2020-2022)
Table 17. Global Biologics CDMO Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Biologics CDMO Revenue Market Share by Company (2020-2022)
Table 19. Global Biologics CDMO Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Biologics CDMO Producing Area Distribution and Sales Area
Table 21. Players Biologics CDMO Products Offered
Table 22. Biologics CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biologics CDMO Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Biologics CDMO Sales Market Share Geographic Region (2017-2022)
Table 27. Global Biologics CDMO Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Biologics CDMO Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Biologics CDMO Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Biologics CDMO Sales Market Share by Country/Region (2017-2022)
Table 31. Global Biologics CDMO Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Biologics CDMO Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 34. Americas Biologics CDMO Sales Market Share by Country (2017-2022)
Table 35. Americas Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 37. Americas Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 38. Americas Biologics CDMO Sales Market Share by Type (2017-2022)
Table 39. Americas Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 40. Americas Biologics CDMO Sales Market Share by Application (2017-2022)
Table 41. APAC Biologics CDMO Sales by Region (2017-2022) & (K Units)
Table 42. APAC Biologics CDMO Sales Market Share by Region (2017-2022)
Table 43. APAC Biologics CDMO Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Biologics CDMO Revenue Market Share by Region (2017-2022)
Table 45. APAC Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 46. APAC Biologics CDMO Sales Market Share by Type (2017-2022)
Table 47. APAC Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 48. APAC Biologics CDMO Sales Market Share by Application (2017-2022)
Table 49. Europe Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 50. Europe Biologics CDMO Sales Market Share by Country (2017-2022)
Table 51. Europe Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 53. Europe Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 54. Europe Biologics CDMO Sales Market Share by Type (2017-2022)
Table 55. Europe Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 56. Europe Biologics CDMO Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Biologics CDMO Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Biologics CDMO Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Biologics CDMO Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Biologics CDMO
Table 66. Key Market Challenges & Risks of Biologics CDMO
Table 67. Key Industry Trends of Biologics CDMO
Table 68. Biologics CDMO Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Biologics CDMO Distributors List
Table 71. Biologics CDMO Customer List
Table 72. Global Biologics CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Biologics CDMO Sales Market Forecast by Region
Table 74. Global Biologics CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Biologics CDMO Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Biologics CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Biologics CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Biologics CDMO Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Biologics CDMO Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Biologics CDMO Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Biologics CDMO Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Biologics CDMO Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Biologics CDMO Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Biologics CDMO Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Biologics CDMO Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lonza Group AG Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 93. Lonza Group AG Biologics CDMO Product Offered
Table 94. Lonza Group AG Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lonza Group AG Main Business
Table 96. Lonza Group AG Latest Developments
Table 97. Samsung Biologics Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 98. Samsung Biologics Biologics CDMO Product Offered
Table 99. Samsung Biologics Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Samsung Biologics Main Business
Table 101. Samsung Biologics Latest Developments
Table 102. AbbVie Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 103. AbbVie Biologics CDMO Product Offered
Table 104. AbbVie Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. AbbVie Main Business
Table 106. AbbVie Latest Developments
Table 107. WuXi Biologics Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 108. WuXi Biologics Biologics CDMO Product Offered
Table 109. WuXi Biologics Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. WuXi Biologics Main Business
Table 111. WuXi Biologics Latest Developments
Table 112. Toyobo Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 113. Toyobo Biologics CDMO Product Offered
Table 114. Toyobo Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Toyobo Main Business
Table 116. Toyobo Latest Developments
Table 117. AGC Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 118. AGC Biologics CDMO Product Offered
Table 119. AGC Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AGC Main Business
Table 121. AGC Latest Developments
Table 122. Thermo Fisher Scientific Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 123. Thermo Fisher Scientific Biologics CDMO Product Offered
Table 124. Thermo Fisher Scientific Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Thermo Fisher Scientific Main Business
Table 126. Thermo Fisher Scientific Latest Developments
Table 127. ICON Plc Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 128. ICON Plc Biologics CDMO Product Offered
Table 129. ICON Plc Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ICON Plc Main Business
Table 131. ICON Plc Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Biologics CDMO Product Offered
Table 134. Boehringer Ingelheim Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Fujifilm Diosynth Biotechnologies Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 138. Fujifilm Diosynth Biotechnologies Biologics CDMO Product Offered
Table 139. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Fujifilm Diosynth Biotechnologies Main Business
Table 141. Fujifilm Diosynth Biotechnologies Latest Developments
Table 1. Biologics CDMO Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biologics CDMO Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Biological Agent
Table 4. Major Players of Biosimilar Drug
Table 5. Global Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 6. Global Biologics CDMO Sales Market Share by Type (2017-2022)
Table 7. Global Biologics CDMO Revenue by Type (2017-2022) & ($ million)
Table 8. Global Biologics CDMO Revenue Market Share by Type (2017-2022)
Table 9. Global Biologics CDMO Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 11. Global Biologics CDMO Sales Market Share by Application (2017-2022)
Table 12. Global Biologics CDMO Revenue by Application (2017-2022)
Table 13. Global Biologics CDMO Revenue Market Share by Application (2017-2022)
Table 14. Global Biologics CDMO Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Biologics CDMO Sales by Company (2020-2022) & (K Units)
Table 16. Global Biologics CDMO Sales Market Share by Company (2020-2022)
Table 17. Global Biologics CDMO Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Biologics CDMO Revenue Market Share by Company (2020-2022)
Table 19. Global Biologics CDMO Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Biologics CDMO Producing Area Distribution and Sales Area
Table 21. Players Biologics CDMO Products Offered
Table 22. Biologics CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biologics CDMO Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Biologics CDMO Sales Market Share Geographic Region (2017-2022)
Table 27. Global Biologics CDMO Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Biologics CDMO Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Biologics CDMO Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Biologics CDMO Sales Market Share by Country/Region (2017-2022)
Table 31. Global Biologics CDMO Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Biologics CDMO Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 34. Americas Biologics CDMO Sales Market Share by Country (2017-2022)
Table 35. Americas Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 37. Americas Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 38. Americas Biologics CDMO Sales Market Share by Type (2017-2022)
Table 39. Americas Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 40. Americas Biologics CDMO Sales Market Share by Application (2017-2022)
Table 41. APAC Biologics CDMO Sales by Region (2017-2022) & (K Units)
Table 42. APAC Biologics CDMO Sales Market Share by Region (2017-2022)
Table 43. APAC Biologics CDMO Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Biologics CDMO Revenue Market Share by Region (2017-2022)
Table 45. APAC Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 46. APAC Biologics CDMO Sales Market Share by Type (2017-2022)
Table 47. APAC Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 48. APAC Biologics CDMO Sales Market Share by Application (2017-2022)
Table 49. Europe Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 50. Europe Biologics CDMO Sales Market Share by Country (2017-2022)
Table 51. Europe Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 53. Europe Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 54. Europe Biologics CDMO Sales Market Share by Type (2017-2022)
Table 55. Europe Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 56. Europe Biologics CDMO Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Biologics CDMO Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Biologics CDMO Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Biologics CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Biologics CDMO Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biologics CDMO Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Biologics CDMO Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Biologics CDMO Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Biologics CDMO Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Biologics CDMO
Table 66. Key Market Challenges & Risks of Biologics CDMO
Table 67. Key Industry Trends of Biologics CDMO
Table 68. Biologics CDMO Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Biologics CDMO Distributors List
Table 71. Biologics CDMO Customer List
Table 72. Global Biologics CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Biologics CDMO Sales Market Forecast by Region
Table 74. Global Biologics CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Biologics CDMO Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Biologics CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Biologics CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Biologics CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Biologics CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Biologics CDMO Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Biologics CDMO Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Biologics CDMO Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Biologics CDMO Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Biologics CDMO Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Biologics CDMO Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Biologics CDMO Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Biologics CDMO Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lonza Group AG Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 93. Lonza Group AG Biologics CDMO Product Offered
Table 94. Lonza Group AG Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lonza Group AG Main Business
Table 96. Lonza Group AG Latest Developments
Table 97. Samsung Biologics Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 98. Samsung Biologics Biologics CDMO Product Offered
Table 99. Samsung Biologics Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Samsung Biologics Main Business
Table 101. Samsung Biologics Latest Developments
Table 102. AbbVie Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 103. AbbVie Biologics CDMO Product Offered
Table 104. AbbVie Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. AbbVie Main Business
Table 106. AbbVie Latest Developments
Table 107. WuXi Biologics Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 108. WuXi Biologics Biologics CDMO Product Offered
Table 109. WuXi Biologics Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. WuXi Biologics Main Business
Table 111. WuXi Biologics Latest Developments
Table 112. Toyobo Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 113. Toyobo Biologics CDMO Product Offered
Table 114. Toyobo Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Toyobo Main Business
Table 116. Toyobo Latest Developments
Table 117. AGC Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 118. AGC Biologics CDMO Product Offered
Table 119. AGC Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AGC Main Business
Table 121. AGC Latest Developments
Table 122. Thermo Fisher Scientific Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 123. Thermo Fisher Scientific Biologics CDMO Product Offered
Table 124. Thermo Fisher Scientific Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Thermo Fisher Scientific Main Business
Table 126. Thermo Fisher Scientific Latest Developments
Table 127. ICON Plc Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 128. ICON Plc Biologics CDMO Product Offered
Table 129. ICON Plc Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ICON Plc Main Business
Table 131. ICON Plc Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Biologics CDMO Product Offered
Table 134. Boehringer Ingelheim Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Fujifilm Diosynth Biotechnologies Basic Information, Biologics CDMO Manufacturing Base, Sales Area and Its Competitors
Table 138. Fujifilm Diosynth Biotechnologies Biologics CDMO Product Offered
Table 139. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Fujifilm Diosynth Biotechnologies Main Business
Table 141. Fujifilm Diosynth Biotechnologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biologics CDMO
Figure 2. Biologics CDMO Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics CDMO Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Biologics CDMO Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biologics CDMO Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Biological Agent
Figure 10. Product Picture of Biosimilar Drug
Figure 11. Global Biologics CDMO Sales Market Share by Type in 2021
Figure 12. Global Biologics CDMO Revenue Market Share by Type (2017-2022)
Figure 13. Biologics CDMO Consumed in Cell Therapy
Figure 14. Global Biologics CDMO Market: Cell Therapy (2017-2022) & (K Units)
Figure 15. Biologics CDMO Consumed in Drug Development
Figure 16. Global Biologics CDMO Market: Drug Development (2017-2022) & (K Units)
Figure 17. Biologics CDMO Consumed in Others
Figure 18. Global Biologics CDMO Market: Others (2017-2022) & (K Units)
Figure 19. Global Biologics CDMO Sales Market Share by Application (2017-2022)
Figure 20. Global Biologics CDMO Revenue Market Share by Application in 2021
Figure 21. Biologics CDMO Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Biologics CDMO Revenue Market Share by Company in 2021
Figure 23. Global Biologics CDMO Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Biologics CDMO Revenue Market Share by Geographic Region in 2021
Figure 25. Global Biologics CDMO Sales Market Share by Region (2017-2022)
Figure 26. Global Biologics CDMO Revenue Market Share by Country/Region in 2021
Figure 27. Americas Biologics CDMO Sales 2017-2022 (K Units)
Figure 28. Americas Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 29. APAC Biologics CDMO Sales 2017-2022 (K Units)
Figure 30. APAC Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 31. Europe Biologics CDMO Sales 2017-2022 (K Units)
Figure 32. Europe Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Biologics CDMO Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 35. Americas Biologics CDMO Sales Market Share by Country in 2021
Figure 36. Americas Biologics CDMO Revenue Market Share by Country in 2021
Figure 37. United States Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Biologics CDMO Sales Market Share by Region in 2021
Figure 42. APAC Biologics CDMO Revenue Market Share by Regions in 2021
Figure 43. China Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Biologics CDMO Sales Market Share by Country in 2021
Figure 50. Europe Biologics CDMO Revenue Market Share by Country in 2021
Figure 51. Germany Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Biologics CDMO Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Biologics CDMO Revenue Market Share by Country in 2021
Figure 58. Egypt Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Biologics CDMO in 2021
Figure 64. Manufacturing Process Analysis of Biologics CDMO
Figure 65. Industry Chain Structure of Biologics CDMO
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Biologics CDMO
Figure 2. Biologics CDMO Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics CDMO Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Biologics CDMO Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biologics CDMO Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Biological Agent
Figure 10. Product Picture of Biosimilar Drug
Figure 11. Global Biologics CDMO Sales Market Share by Type in 2021
Figure 12. Global Biologics CDMO Revenue Market Share by Type (2017-2022)
Figure 13. Biologics CDMO Consumed in Cell Therapy
Figure 14. Global Biologics CDMO Market: Cell Therapy (2017-2022) & (K Units)
Figure 15. Biologics CDMO Consumed in Drug Development
Figure 16. Global Biologics CDMO Market: Drug Development (2017-2022) & (K Units)
Figure 17. Biologics CDMO Consumed in Others
Figure 18. Global Biologics CDMO Market: Others (2017-2022) & (K Units)
Figure 19. Global Biologics CDMO Sales Market Share by Application (2017-2022)
Figure 20. Global Biologics CDMO Revenue Market Share by Application in 2021
Figure 21. Biologics CDMO Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Biologics CDMO Revenue Market Share by Company in 2021
Figure 23. Global Biologics CDMO Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Biologics CDMO Revenue Market Share by Geographic Region in 2021
Figure 25. Global Biologics CDMO Sales Market Share by Region (2017-2022)
Figure 26. Global Biologics CDMO Revenue Market Share by Country/Region in 2021
Figure 27. Americas Biologics CDMO Sales 2017-2022 (K Units)
Figure 28. Americas Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 29. APAC Biologics CDMO Sales 2017-2022 (K Units)
Figure 30. APAC Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 31. Europe Biologics CDMO Sales 2017-2022 (K Units)
Figure 32. Europe Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Biologics CDMO Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Biologics CDMO Revenue 2017-2022 ($ Millions)
Figure 35. Americas Biologics CDMO Sales Market Share by Country in 2021
Figure 36. Americas Biologics CDMO Revenue Market Share by Country in 2021
Figure 37. United States Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Biologics CDMO Sales Market Share by Region in 2021
Figure 42. APAC Biologics CDMO Revenue Market Share by Regions in 2021
Figure 43. China Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Biologics CDMO Sales Market Share by Country in 2021
Figure 50. Europe Biologics CDMO Revenue Market Share by Country in 2021
Figure 51. Germany Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Biologics CDMO Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Biologics CDMO Revenue Market Share by Country in 2021
Figure 58. Egypt Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Biologics CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Biologics CDMO in 2021
Figure 64. Manufacturing Process Analysis of Biologics CDMO
Figure 65. Industry Chain Structure of Biologics CDMO
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
